Chemical ID: CAS Formula HS Code Database

DL-Alanine: Product Identification

Property	Manufacturer Commentary
Product Name	DL-Alanine
IUPAC Name	2-Aminopropanoic acid
Chemical Formula	C3H7NO2
CAS Number	DL-Alanine covers racemic mixtures; commonly referenced as CAS 302-72-7 for manufacturing purposes. The specification depends on whether the product is sold as technical grade, feed grade, or for other uses, as validated by batch release documentation.
Synonyms & Trade Names	Often identified in procurement and logistics as Racemic Alanine, 2-Aminopropionic acid, or α-Alanine. Naming conventions vary depending on the buying region and customer system identification requirements. Internal and regional trade codes can differ, and variation is mapped in the product master data per grade.
HS Code & Customs Classification	For customs, the majority of shipments are classified under 2922.49, covering amino acids and their derivatives. In some jurisdictions, more specific sub-coding may be adopted to distinguish racemic forms or to meet excise audit trail requirements. Final code assignment typically aligns with the declared use—whether as an intermediate, animal feed ingredient, or nutritional additive—and is confirmed with each consignment per shipping document. Discrepancies in local and international interpretation of HS codes require routine review with customs consultants as regulatory standards evolve.

DL-Alanine: Technical Properties, Manufacturing Process & Safety Guidelines

Physical & Chemical Properties

Physical State & Appearance

Industrial DL-Alanine generally appears as a white crystalline powder without any significant odor. Form and appearance shift depending on crystallization methods and particle size reduction steps. Particle size specification remains a customer-driven parameter and impacts solubility, dissolution rate, and blending in downstream formulations. Batch-to-batch consistency in color provides an early check against process deviations or contaminant introduction; off-color material calls for root cause analysis before shipment.

Melting Point, Boiling Point, Flash Point, Density

Observed melting point ranges span grade and water activity content; precise values for analytical and pharmaceutical grades are confirmed via DSC or capillary analysis. Other thermal properties, such as flash point and boiling point, rarely influence safety assessments or storage approach since DL-Alanine is non-volatile and non-flammable under typical warehouse conditions. Density varies with compaction and packaging; bulk density readings inform silo, conveyance, and dissolution system design.

Chemical Stability & Reactivity

Chemical stability relies on exclusion of excessive heat, moisture ingress, and oxidizing contaminants. DL-Alanine stays chemically inert under ambient conditions; stability decreases with elevated humidity, leading to caking or slow degradation. Batch retention studies align shelf-life claims with real storage rather than relying on theoretical predictions.

Solubility & Solution Preparation

DL-Alanine dissolves readily in water; solubility is grade- and temperature-dependent. Dust formation during dissolution is mitigated with wetting aids or agitation; solution clarity indicates adequate purification at upstream stages. Practically, end-users demand rapid, residue-free dissolution for high-purity and injectable grades, requiring rigorous particulate control before batch release.

Technical Specifications & Quality Parameters

Specification Table by Grade

Specifications diverge sharply between applications: feed grade, industrial, food additive, and pharmaceutical/injectable grades each align with their own acceptance ranges for assay, moisture, heavy metals, and micro contaminants.

Parameter	Feed Grade	Food/Pharma Grade	Test Method
Assay (DL-Alanine)	Typical values specified by customer	Defined per pharmacopeia or client spec	Titration/HPLC
Moisture	Custom limits	Pharmacopeia/commercial agreement	Loss on drying/Karl Fischer
Heavy Metals	Process control levels	Stricter release, e.g. <1 ppm	ICP/MS, AAS

Final impurity release thresholds always respond to end-use requirements, not generic standards. Process route influences which trace inorganics and organics require monitoring.

Impurity Profile & Limits

Significant impurities may arise from incomplete racemization, side reactions, or residual catalysts. Each production route has its own typical impurity signature. All critical impurities feature regular monitoring, with limits specified on a per-grade basis. Downstream use in APIs or food-contact products drives targeted testing for specified microbials, pyrogens, or leachables.

Test Methods & Standards

Analytical protocols match customer, regulatory, and industry requirements: compendium methods for food/pharma routes and validated in-house methods for industrial/feed applications. Methods referenced from regional pharmacopeia or ISO; alternative methods cross-validated as part of ongoing QA.

Preparation Methods & Manufacturing Process

Raw Materials & Sourcing

Main raw materials for DL-Alanine manufacturing differ by process: petrochemical-derived intermediates or bio-based feedstocks. Raw material traceability and impurity load significantly influence final product selection, especially for high-purity markets. Vendors undergo qualification based on metal, residue, and bioburden profiles.

Synthesis Route & Reaction Mechanism

DL-Alanine at scale is manufactured via:

• Chemical racemization of L-Alanine, requiring control over racemization efficiency and byproduct minimization, or
• Direct Strecker synthesis routes, raising concerns about inorganic and nitrile-related impurities, or
• Biocatalytic conversion capable of tighter isomer ratios for specialty grades.

Process route selection hinges on required purity, volume, and downstream application. Feed, industrial, and technical grades typically adopt cost-favored chemical routes. Pharma and food grades rely on rigorously validated, low-impurity pathways with robust segregation from allergenic or restricted process aids.

Process Control & Purification

Continuous monitoring during synthesis tracks completeness of reaction, byproduct formation, and catalyst carryover. Filtration, activated carbon treatment, and multi-stage recrystallization form the backbone of purification, tailored for impurity sensitivity per grade. Batch records detail analysis at critical control points, with deviation triggers for any excursions from validated performance.

Quality Control & Batch Release

QA procedures include layered in-process checks (yield estimates, color, pH, preliminary impurity scans) and batch release critical quality attributes (assay, heavy metals, organoleptic inspection). Customer-specific release standards override internal specifications for tailored markets. Retain samples support retrospective analysis in case of quality complaints.

Chemical Reactions & Modification Potential

Typical Reactions

DL-Alanine readily participates in peptide bond formation, esterification, amidation, and standard amino acid derivatization. Reaction performance depends on purity, isomer ratio, and contaminant background—all of which stem from upstream process choices.

Reaction Conditions

Forming esters or amides from DL-Alanine calls for acidic or activating agents, optionally using catalysts like carbodiimides for peptide synthesis. Solvent and temperature parameters are tuned to minimize racemization or byproduct formation. For downstream modification, control over residual moisture and inorganic salts affects both yield and downstream processing.

Derivatives & Downstream Products

Major derivative products include alanine esters, peptide intermediates, and specialty surfactant precursors. The suitability of a particular DL-Alanine grade for such transformations relies on impurity limits, physical state, and absence of interfering metals or organics.

Storage & Shelf Life

Storage Conditions

DL-Alanine must stay dry and protected from environmental moisture. Uncontrolled humidity accelerates caking, alters flow, and increases risk of slow hydrolytic degradation. Storage below room temperature and out of direct light extends shelf life for all high-purity and food/pharma grades.

Container Compatibility

HDPE, stainless steel, and inert-coated drums prevent interaction with product; avoid reactive or absorbent materials for long-term storage. Packaging selection reflects destination use, local climate, and transportation mode, as permeability and weight limits vary.

Shelf Life & Degradation Signs

Shelf life varies according to grade, water content, packaging integrity, and storage controls. Official shelf life declarations rely on real-time and accelerated stability testing. Typical degradation signs include discoloration, caking, off-odor, and visible particulates; any such observation calls for hold and investigation prior to use.

Safety & Toxicity Profile

GHS Classification

DL-Alanine is not classified as hazardous under global GHS systems for most commercial grades. Special attention is paid to dust generation and possible respiratory irritation in bulk handling. Any change in impurity profile due to alternative synthesis may affect hazard labelling.

Hazard & Precautionary Statements

Routine occupational precautions address dust inhalation in production and packaging areas—dust masks and local exhaust ventilation standard in high-throughput settings or during repackaging. Eye contact avoided; eye wash stations installed in production areas.

Toxicity Data

No acute toxicity expected at industrial exposure levels for DL-Alanine alone. Trace-level impurities from raw material residues, processing agents, or cross-contamination are subject to risk assessment and removal for pharmaceutical and food applications.

Exposure Limits & Handling

No established regulatory occupational exposure limits for DL-Alanine. Handling practices prioritize minimizing airborne particulate. For production operators, full PPE in powder charging and screening steps advised to avoid cumulative exposures, especially where ventilation is not fully enclosed.

DL-Alanine: Supply Capacity, Commercial Terms & 2026 Price Trend Forecast

Supply Capacity & Commercial Terms

Production Capacity & Availability

In industrial-scale production, annual DL-Alanine capacity reflects the route selection between racemization of L-Alanine and direct chemical synthesis. Production output fluctuates based on raw material access and batch cycle optimization. Grade-specific capacity controls inventory planning, with a distinct separation between feed, pharma-intermediate, and technical grades. Availability tightens against spikes in demand from pharmaceutical, food, and animal feed sectors, each holding different release deadlines and consistency requirements.

Lead Time & MOQ

Lead time for standard grades averages several weeks from order confirmation, considering alignment of batch scheduling, QA clearance, and export documentation. MOQ varies with grade, purpose, and downstream packaging, often driven by batch homogeneity targets and campaign-based manufacturing strategies. MOQ for pharma and high-purity applications remains higher than technical grades, as changeover increases risk of cross-contamination and necessitates longer equipment downtime for cleaning validation.

Packaging Options

Bulk packaging in fiber drums or multi-layer bags dominates shipments above 500 kg, designed to safeguard against ambient moisture ingress and cross-contact during transit. Packing material and size depend on customer’s requirements, product grade, and shelf-life expectations. For pharma and food-grade deliveries, internal liners and tamper-evident seals follow compliance with customer and regulatory protocols.

Shipping & Payment Terms

Shipping routes hinge on region and customer urgency, with most exports carried via FCL/LCL sea shipments or air cargo for just-in-time scenarios. Payment terms lean toward LC or upfront deposits, especially when orders draw from dedicated campaign production or non-standard packaging. Pricing and reservation terms adjust case-by-case to reflect inventory risk and customer relationship depth.

Pricing Structure & Influencing Factors

Raw Material Cost Composition

DL-Alanine operates under a cost structure sensitive to upstream chemicals such as acetaldehyde, ammonia, and related intermediates. Feedstock volatility ties closely to energy prices, refinery fluctuations, and global chemical supply dynamics, leading to inconsistent baseline costs. Additional conversion costs stem from hydrogenation, catalyst consumption, and purification steps. Process yield, batch rework rates, and recovery of side streams add further price complexity.

Fluctuation Causes

Price instability arises from shifts in feedstock market, geographical supply disruptions, environment-related shutdowns, and downstream demand from pharma excipients and specialty amino acid derivatives. Any local regulation on precursor chemicals, energy rationing, or labor supply crunch impacts not just cost but also production reliability.

Product Price Difference Explanation: Grade, Purity, and Packaging Certification

The price spread across grades reflects more than just purity percentage. Elevated pricing for pharmaceutical and food grades comes from stage-by-stage QA/QC, validated cleaning, and full traceability. Specialized packaging drives logistics and compliance costs, inflating delivered price over technical grade. Certification cost is non-negligible: GMP, ISO, or HACCP batch certification triggers additional analytical release work, process validation, and document issuance, all reflected in final pricing tiers.

Global Market Analysis & Price Trends

Global Supply & Demand Overview

Global supply mirrors trends in upstream chemical markets and regional capacity investments, with Asian producers covering the bulk of technical and feedstock-grade output. North American and EU facilities target high-purity grades with comparatively lower volumes but stricter regulatory documentation. Demand fluctuates according to pharmaceutical pipeline approvals, food fortification trends, and animal feed fortification programs in key regions.

Key Economies Analysis

Region	Characteristic Demand/Production	Key Observations
US	Pharma and fine chemical segments	Emphasis on compliance and traceability; persistent demand for high-grade DL-Alanine
EU	Food and nutraceuticals	Stringent safety, preference for local QA release documentation
JP	High-purity, electronic, specialty blending	Preference for sub-lot traceability and advanced impurity profiling
IN	Feed and technical use rising	Bulk imports; pricing sensitive to global market fluctuations
CN	Major technical and pharmaceutical intermediate producer	Dominant capacity for export; variable QA standards by grade

2026 Price Trend Forecast

Pricing through 2026 is tracking toward moderate escalation considering projected volatility in feedstock prices and ongoing production decentralization. Continued regulatory tightening on intermediates and potential for environmental controls in major producing regions (notably China and Southeast Asia) create upward price exposure. End-user certification requirements add systematic cost in high-grade segments. Technical grade prices expected to remain more volatile than pharma/food grades, which benefit from longer-term supply contracts.

Data Sources & Methodology

This analysis synthesizes plant production experience, ongoing engagement with raw material traders, and industry monitoring via published chemical indexes and sector reports. Market insights stem from direct customer feedback and internal benchmarking against export shipment patterns.

Industry News & Regulatory Updates

Recent Market Developments

Environmental impact assessments for manufacturing sites have gained increased attention across Asia, affecting approval timelines for new capacity and plant expansion. Some upstream chemical producers facing heightened environmental oversight have temporarily reduced their output, constraining DL-Alanine supply chain stability.

Regulatory Compliance Updates

Major regulatory bodies in the EU and North America recently updated food contact and pharma excipient guidelines, particularly focusing on trace-level impurity control and cross-contamination risk in multi-purpose facilities. The demand for documented traceability and risk management protocols increased accordingly.

Supplier Response & Mitigation

Manufacturer adaptations include increased investment in in-process control analytics, batch segregation, and verification of cleaning validation. Customer-specific certification requests dictate adjustments in documentation and release structure, especially regarding impurity profile certification and process auditability. Capacity reallocation toward high-certification segments is underway to align with evolving compliance demands and partner expectations.

DL-Alanine Application Fields & Grade Selection Guide

Application Fields & Grade Matching Guide

Industry Applications

DL-Alanine production supports a range of industrial uses. Each sector presents different requirements for purity, contaminants, and performance attributes. Major application zones include amino acid-based feed supplements, pharmaceutical intermediates, food additives, and technical uses such as biological research and buffer preparation. Across regions, regulatory standards and grades demanded by downstream users shape which grades are considered fit for each segment.

Grade-to-Application Mapping

Application Sector	Usual Grade	Key Technical Focus
Feed Additives	Feed Grade	Acceptable residual ammonia, organic impurities below threshold; particle size suitable for uniform mixing into premixes; compliance with animal nutrition regulations
Pharmaceuticals	Pharma Grade	Low bioburden, heavy metals within region-defined limits, process documentation for each batch, genotoxic impurities assessed as per GMP guidance
Food Additives	Food Grade	Pesticide residues and solvents tested to food-use standards; trace element profile aligns with regional food codes; NOAEL-based impurity profiling
Research & Technical	Laboratory Grade / Technical Grade	Residual solvent and moisture monitored batch-wise, less stringent impurity control compared to food/pharma; prioritizes cost and consistent handling properties

Key Parameters by Application

Parameters controlling application fit include purity, enantiomeric excess, solubility, sodium content, and specific test profiles for residual solvents, metals, and microbiological safety. Higher-value routes require documented process controls, traceable raw materials, and analytical batch records. Feed applications often tolerate higher impurity thresholds than food or pharma, but demand reliable blending flow properties and tested nutritional equivalence. Pharmaceutical and food supply routes include defined endotoxin limits and allergen risk assessments on every lot.

How to Select the Right Grade

Step 1: Define Application

Clarify whether the use aligns with animal nutrition, human food, pharmaceutical synthesis, or analytical work. Each sector drives unique impurity, trace element, and documentation requirements that affect grade selection.

Step 2: Identify Regulatory Requirements

Map your destination market’s regulatory standards. Food and pharma grades must conform to Codex Alimentarius, USP, EP, FCC, or regional equivalents, often requiring audit-traceable manufacturing records and material flows. Feed grades abide by distinct animal safety frameworks, varying by region.

Step 3: Evaluate Purity Needs

Within each sector, purity targets and impurity exclusions depend on both the grade and application risk profile. Pharmaceutical applications validate low heavy metals, genotoxic/organic impurities, and strict residual solvent compliance. Food grade tolerances differ by regulatory region, whereas technical grades may permit broader impurity ranges for cost reasons. Request current CoA’s as specifications and batch-to-batch consistency are not uniform across suppliers or manufacturing sites.

Step 4: Consider Volume & Budget

Large-scale feed or technical use often prioritizes stable supply and process suitability; cost pressures may permit selection of grades with less rigorous analytical documentation or impurity exclusion, provided these parameters do not interfere with downstream application or regulatory acceptance. Food and pharma supply chains must account for extra quality assurance measures, traceability controls, and documentation, reflected in both price and lead time.

Step 5: Request Sample for Validation

Before finalizing sourcing, request representative samples. Conduct in-process and final product trials under your actual operating conditions. Assess typical impurity profile, physical handling properties, packaging, and analytical documentation—not just manufacturer claims—to ensure reliable integration into downstream formulations or controls.

Trust & Compliance: Quality Certifications & Procurement Support for DL-Alanine

Quality Compliance & Certifications

Quality Management Certifications

In DL-Alanine production, maintaining process verification forms the backbone of quality assurance. Our facility holds recognized quality management certifications that reflect both internal commitment and external regulatory fulfillment. Certifications such as ISO 9001 demonstrate a structured approach to process control, traceability, and documentation management down to batch and lot identification. These standards do not prescribe product features, but they do drive deployment of documented corrective action responses, production record review, and regular revalidation of both process and instrumentation.

Product-Specific Certifications

DL-Alanine certification profiles are tightly linked to application tiers. For pharmaceutical or food ingredient grades, certifications—like GMP or regional food safety registrations—depend on both process design and end-use legal frameworks. Typical compliance audits target raw material qualification logic, records for full traceability downstream, and defined response plans for non-conformances or out-of-specification materials. When serving specialty chemical segments, process certifications or third-party audits focus more on impurity control points and segregation strategies for byproduct management, calibrated for each grade’s specification and production method.

Documentation & Reports

Each shipping lot is accompanied by a full-scale Certificate of Analysis, covering agreed-upon attributes as defined by grade or purchaser requirements. COAs report actual batch measurements for properties such as appearance, assay, and key impurity markers—results always cited using current internal QC protocols and, where requested, using mutually agreed external references. In special circumstances, dossier packages may also include detailed change-control history, full analytical raw data, and audit support records. Long-term archiving protocols ensure that historic quality documentation can be retrieved for retrospective product risk assessments, process change justifications, or regulatory authority requests.

Purchase Cooperation Instructions

Stable Production Capacity Supply and Flexible Business Cooperation Plan

Forecasting and production planning strategies are set up to support both large-volume call-offs and specialty order sizes. For core DL-Alanine production, backward integration and multi-batch production lines buffer supply risk and help sustain year-round availability. Contract flexibility comes from multi-tiered supply programs, including consignment, scheduled delivery, and ad-hoc ordering, each supported by an internal ERP system for transparent order tracking and status updating. Risk-of-supply mitigation is prioritized through raw material inventory coverage and process route redundancy.

Core Production Capacity and Stable Supply Capability

Production lines operate on validated process windows, managed to sustain consistency over multiple campaigns. Actual output varies by campaign length and operational demand, with capability reserves held for urgent scale-up if customers require accelerated replenishment. Regular maintenance and proactive root-cause analysis in production scheduling guard against critical process interruptions. For high-purity or regulatory-sensitive DL-Alanine, batch scheduling ensures changeovers and cleaning sequences meet product isolation requirements. This strategy is supported by in-process controls on key attributes linked to supply obligations for specific market segments.

Sample Application Process

Sample request handling is systematized to ensure that provided material reflects production batch conditions, not laboratory-prepared quantities. Typical sample sizes follow application type and customer trial requirements. Upon receiving a sample inquiry, technical and quality teams verify material traceability, provide batch-specific COAs, and, when needed, annex processing or test history reports. Priority sampling is available for technical validation or registration support projects, with guided follow-up for feedback on actual downstream performance. Any special documentation associated with sample batches follows the final use-case and regional compliance standards.

Detailed Explanation of Flexible Cooperation Mode

Cooperation models range from fixed-term offtake contracts to project-based joint development agreements. Spot supply, periodic review contracts, and demand-pull logistics are all available based on customer forecast accuracy and project horizon. For OEM or toll manufacturing fills, dedicated campaign runs may be scheduled with process parameter adjustment aligned to customer inputs. Built-in flexibility allows for dual-site or multi-batch pooling, inventory storage agreements, and feedstock preference matching—always with transparency about production status, potential disruption risks, and agreed process change notifications. Custom frameworks, including split-shipment, multi-modal transport options, and phased supply, are defined case by case through technical development and commercial alignment teams.

DL-Alanine: Market Forecast & Technical Support System

Research & Development Trends

Current R&D Hotspots

Research activity in DL-Alanine focuses on raw material sourcing methods, process refinement, and impurity control. Production teams evaluate alternative synthesis pathways, comparing traditional ammonolysis and enzymatic racemization methods. The push for lower residual solvent content requires adjustments to solvent recovery units and vacuum drying protocols. In-process analytical techniques, such as HPLC and polarimetry, are being adapted to detect trace enantiomeric excess and quantify batch-to-batch consistency. Quality control teams keep a close watch on racemization completeness and develop control charts that specifically monitor chiral purity drift over campaign runs.

Emerging Applications

In recent years, demand has expanded beyond classical pharmaceutical and feed uses. Downstream customers in electrochemistry and biodegradable polymer development request application-oriented support, especially where non-proteinogenic amino acid integration plays a technical role. High-purity DL-Alanine is being trialed as a stabilizer in specific electrolyte matrices and as a ring-opening polymerization modulator. These applications require predictable purity profiles and tailored particle sizes, both of which challenge the industry’s traditional specification mindset.

Technical Challenges & Breakthroughs

Routine industrial production encounters technical bottlenecks in impurity removal and color body suppression. Process engineers note that most byproduct formation correlates to starting material impurity load and catalyst selectivity drift over extended operations. Operational improvements have included implementing real-time analytics at key purification nodes. Facility upgrades are moving toward closed-loop solvent management to mitigate fugitive emissions and reduce solvent impurity footprints. Success has been greatest where cross-functional teams directly integrate analytical development with production campaigns, enabling rapid troubleshooting and adaptive process control.

Future Outlook

Market Forecast (3-5 Years)

Market demand for DL-Alanine fluctuates between grades and regions, with more growth anticipated in pharmaceutical intermediates and electronic material manufacturing. Feed and food segments anchor volume stability, but specialty markets—especially those tied to green processing and biodegradable plastics—are expected to consume higher-purity and chemically customized grades. Volume contracts are shifting toward multi-year supply relationships, with end users requesting detailed impurity disclosure and long-term batch consistency documentation. Regional regulatory regimes further shape specification trends, especially for pharmaceutical and food-contact applications.

Technological Evolution

Process intensification remains a core focus, especially through continuous production designs and integration of membrane-based separation steps for final product isolation. Technology teams monitor developments in enzymatic catalysts, as future generation biocatalysts could enable lower temperature synthesis and reduce racemization energy intensity. Adoption of digital twins is ongoing, aiming to better predict batch deviations and support rapid root-cause analyses when deviations occur. Traceability and real-time quality release are becoming embedded expectations for high-value applications.

Sustainability & Green Chemistry

Manufacturing priorities increasingly align with stricter sustainability benchmarks. Raw material selection weighs not only cost and availability, but lifecycle emissions and bio-based sourcing. Solvent selection integrates recoverability and toxicity endpoints, with facility modifications prioritizing closed systems and solvent minimization. Byproduct valorization and water recycling are central to new capital projects, and customers increasingly request scope 3 emissions data as part of contract negotiations. Achieving these goals requires cross-functional engagement from R&D, production, EHS, and supply chain.

Technical Support & After-Sales Service

Technical Consultation

Each customer receives technical support from a chemist or process engineer who understands the manufacturing history, batch analytics, and application sensitivities for their grade of DL-Alanine. The support process includes application troubleshooting, consultation on downstream compatibility, and detailed discussions of specification boundaries. Feedback loops with customers often lead to process refinements or specification adjustments, ensuring better alignment with end-use needs. Routine site audits and collaborative validation tests are standard for key accounts requiring audit-ready traceability and full supply chain visibility.

Application Optimization Support

Batch properties frequently undergo adjustment to support new applications. This includes particle size tuning, alternate crystallization endpoints, or customized impurity profiles. Application engineers coordinate with R&D to modify parameter windows and document the performance impact through lab or pilot-scale trials. Technical reports detail observed compatibility, process yield improvement, and performance stability, always noting which outcomes depend on specific grade or application parameters.

After-Sales Commitment

Supply agreements include ongoing batch traceability, specification re-confirmation, and rapid response to any discrepancy reports. Process quality teams maintain sample retention matching every commercial shipment, enabling retrospective investigations. Complaints trigger joint failure analysis sessions with visibility into retained samples and production batch documentation. The commitment extends to thorough record-keeping, batch reconciliation, and, if required, site-level process review visits. Each resolution includes recommendations for handling, storage, or process adaptation if issues trace back to downstream sensitivities rather than material conformance.

DL-Alanine: Consistent Quality from a Direct Chemical Producer

Manufacturing Capabilities and Product Overview

We produce DL-Alanine as a stable, high-purity white crystalline powder using specialized enzymatic synthesis and proprietary purification steps. Our facility runs round-the-clock, with batch records and full lot tracking, ensuring reproducible output every time. All synthesis, filtration, and drying processes remain under strict monitoring, preventing foreign material inclusion and controlling moisture content for reliable downstream handling.

Industrial Applications Driving Procurement Value

Our DL-Alanine supports a range of industries: pharmaceutical intermediates, food processing, veterinary feed, and high-grade biochemical research. In pharmaceutical synthesis, manufacturers select our material for consistent reaction yields. Food and beverage processors utilize it as a nutritional additive. Veterinary feed producers rely on our stable supply chain to meet volume, cost, and formulation goals.

Quality Control and Batch Consistency

Consistency rests on measurable parameters. Every lot undergoes validated HPLC assay, residual solvent screening, and trace metal analysis. Each drum receives a unique batch number printed on tamper-evident packaging, linked to a digital record of test results, origin date, and handling environment. Daily in-process testing spots deviations early, reducing risk of out-of-spec shipments.

Packaging and Reliable Supply Solutions

Packing lines fill to industrial bulk specifications—drums, lined fiber cartons, or flexible intermediate bulk containers. Moisture and contamination exposure drops through nitrogen-purged sealing. Our inventory control system supports both just-in-time and buffer stocking strategies for contract buyers. Multiple loading bays and dedicated logistics partners keep order fulfillment on schedule, whether the requirement calls for a single pallet or a multi-container shipment.

Technical Support for Industrial Buyers

Chemists and production teams receive hands-on access to our technical engineers. When formulation challenges arise, our production chemists offer direct consults, leveraging years of process experience to address solubility, compatibility, and analytical testing details. Technical support covers documentation for audits, regulatory filings, or downstream traceability requirements—always supplied from our in-house source, without middlemen or layered communication.

Business Value Across the Supply Chain

Manufacturers gain a direct stream of compliant DL-Alanine, reducing sourcing delays and quality risks. Distributors depend on our bulk packaging, stable lead times, and transparent batch records for smooth rerouting to their clients. Procurement teams value the real-time lot access and technical documentation, streamlining their quality assurance and compliance tasks.

From material selection through delivery and technical backup, our direct production, continuous monitoring, and batch-controlled fulfillment model underpin every kilogram supplied.

Industrial FAQ